Evidence map›Paper›PMID 36286477›Full record

ReviewMarine drugs2022

Marine Biological Macromolecules and Chemically Modified Macromolecules; Potential Anticoagulants.

Pathum Chandika, Pipuni Tennakoon, Tae-Hee Kim, Se-Chang Kim, Jae-Young Je, Jae-Il Kim, Bonggi Lee, BoMi Ryu, Hyun Wook Kang, Hyun-Woo Kim and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Bioactive Peptides from Marine Organisms.Protein and peptide letters · 2024
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Pathum ChandikaMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.
Pipuni TennakoonMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.
Tae-Hee KimMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-0988-0193
Se-Chang KimMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.
Jae-Young JeMajor of Human Bioconvergence, Division of Smart Healthcare, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-4800-0566
Jae-Il KimMajor of Food Science and Nutrition, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-6186-5492
Bonggi LeeMajor of Food Science and Nutrition, Pukyong National University, Busan 48513, Korea.
BoMi RyuMajor of Food Science and Nutrition, Pukyong National University, Busan 48513, Korea.ORCID 0000-0001-5797-500X
Hyun Wook KangMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-0861-1354
Hyun-Woo KimMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.ORCID 0000-0003-1357-5893
Young-Mog KimMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-2465-8013
Chang Su KimDepartment of Orthopedic Surgery, Kosin University Gospel Hospital, Busan 49267, Korea.
Il-Whan ChoiDepartment of Microbiology, College of Medicine, Inje University, Busan 47392, Korea.ORCID 0000-0003-3958-6937
Won Sun ParkDepartment of Physiology, Institute of Medical Sciences, School of Medicine, Kangwon National University, Chuncheon 24341, Korea.
Myunggi YiResearch Center for Marine Integrated Bionics Technology, Pukyong National University, Busan 48513, Korea.ORCID 0000-0003-4864-959X
Won-Kyo JungMarine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Korea.ORCID 0000-0002-1615-750X
Pukyong National University · KRInje University · KRKangwon National University · KRKosin University Gospel Hospital · KR

Funding

Korea institute of Marine Science & Technology Promotion KIMST-20220128National Research Foundation of Korea 2021R1A6A1A03039211 and 2019R1A2C1007218
6 · The paper itself

Abstract

Coagulation is a potential defense mechanism that involves activating a series of zymogens to convert soluble fibrinogen to insoluble fibrin clots to prevent bleeding and hemorrhagic complications. To prevent the extra formation and diffusion of clots, the counterbalance inhibitory mechanism is activated at levels of the coagulation pathway. Contrariwise, this system can evade normal control due to either inherited or acquired defects or aging which leads to unusual clots formation. The abnormal formations and deposition of excess fibrin trigger serious arterial and cardiovascular diseases. Although heparin and heparin-based anticoagulants are a widely prescribed class of anticoagulants, the clinical use of heparin has limitations due to the unpredictable anticoagulation, risk of bleeding, and other complications. Hence, significant interest has been established over the years to investigate alternative therapeutic anticoagulants from natural sources, especially from marine sources with good safety and potency due to their unique chemical structure and biological activity. This review summarizes the coagulation cascade and potential macromolecular anticoagulants derived from marine flora and fauna.

Indexed as

AnticoagulantsThrombosisEnzyme PrecursorsFibrinFibrinogenHemorrhageHeparinHumansAnticoagulantsEnzyme PrecursorsFibrinFibrinogenHeparinanticoagulantblood coagulationchemically modified macromoleculesmarine anticoagulant macromoleculesmarine sources

Identifiers

PMID36286477
PMCPMC9604568
OpenAlexW4307582836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.